Ascletis Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Ascletis Pharma has a total shareholder equity of CN¥2.3B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.5B and CN¥148.9M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | n/a |
Cash | CN¥2.30b |
Equity | CN¥2.34b |
Total liabilities | CN¥148.94m |
Total assets | CN¥2.49b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2VJ's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥140.7M).
Long Term Liabilities: 2VJ's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥8.3M).
Debt to Equity History and Analysis
Debt Level: 2VJ is debt free.
Reducing Debt: 2VJ has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 2VJ has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2VJ has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.